PapersFlow Research Brief
Venous Thromboembolism Diagnosis and Management
Research Guide
What is Venous Thromboembolism Diagnosis and Management?
Venous Thromboembolism Diagnosis and Management is the clinical process of preventing, diagnosing, and treating venous thromboembolism (VTE), which encompasses deep vein thrombosis and pulmonary embolism, through antithrombotic therapies, risk assessment, prophylaxis, and adherence to evidence-based guidelines.
The field includes 162,835 published works on VTE prevention, diagnosis, and treatment. Key areas cover antithrombotic therapy, risk factors, prophylaxis, and management in cancer patients. Clinical practice guidelines direct the use of tools like Wells' Criteria for pretest probability assessment.
Topic Hierarchy
Research Sub-Topics
Pulmonary Embolism Diagnosis
This sub-topic covers imaging modalities such as CT pulmonary angiography and D-dimer testing for diagnosing pulmonary embolism. Researchers study diagnostic accuracy, risk stratification algorithms, and integration with clinical decision rules.
Deep Vein Thrombosis Risk Stratification
This sub-topic examines clinical prediction rules like Wells score and Geneva score for assessing DVT probability. Researchers investigate risk factors including surgery, immobility, and genetic predispositions to refine prophylaxis strategies.
Direct Oral Anticoagulants in VTE
This sub-topic focuses on DOACs such as rivaroxaban and apixaban for VTE treatment compared to vitamin K antagonists. Researchers analyze efficacy, bleeding risks, and extended therapy durations in randomized trials.
Cancer-Associated Thrombosis Management
This sub-topic addresses antithrombotic choices like low-molecular-weight heparin and DOACs in cancer patients with VTE. Researchers explore treatment duration, recurrence risks, and interactions with chemotherapy regimens.
VTE Prophylaxis in Surgical Patients
This sub-topic investigates pharmacological and mechanical prophylaxis in orthopedic and general surgery settings. Researchers evaluate guideline adherence, optimal durations, and risk-benefit analyses in high-risk cohorts.
Why It Matters
Venous thromboembolism diagnosis and management reduces mortality and morbidity from deep vein thrombosis and pulmonary embolism, the third most common fatal cardiovascular condition in the United States. Kearon et al. (2012) in "Antithrombotic Therapy for VTE Disease" outline therapies that balance efficacy against bleeding risks, guiding treatment in diverse populations including cancer patients. Geerts et al. (2004) in "Prevention of Venous Thromboembolism" demonstrate prophylaxis reduces VTE incidence postoperatively, with specific recommendations for orthopedic surgery yielding complication reductions. Recent guidelines like the 2025 ESC on acute VTE management in pregnancy and ESVM guidelines on interventional treatments expand options for high-risk groups.
Reading Guide
Where to Start
"Antithrombotic Therapy for VTE Disease" by Kearon et al. (2012), as it provides a foundational overview of treatment strategies directly addressing VTE management with 6102 citations.
Key Papers Explained
Kearon et al. (2012) in "Antithrombotic Therapy for VTE Disease" establishes core treatment principles, complemented by Geerts et al. (2004) in "Prevention of Venous Thromboembolism" focusing on prophylaxis strategies with 5875 citations. Lip et al. (2009) in "Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach" refines risk assessment applicable to VTE contexts (6570 citations). Patel et al. (2011) in "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation" introduces direct oral anticoagulant evidence (9227 citations), building toward guideline integration.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints highlight 2025 ESC Guidelines for acute VTE management in pregnancy by Hobohm et al., ESVM Guidelines on interventional VTE treatments, and protocols for real-time VTE prediction models in hospitalized patients. Meta-analyses on central venous catheter complications inform prophylaxis refinements. AAFP updates emphasize Wells' Criteria in diagnosis.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Correspondence - Tranexamic acid for traumatic brain injury | 2005 | Edinburgh Research Exp... | 11.7K | ✓ |
| 2 | Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | 2011 | New England Journal of... | 9.2K | ✓ |
| 3 | Endovascular thrombectomy after large-vessel ischaemic stroke:... | 2016 | The Lancet | 7.2K | ✕ |
| 4 | Collaborative meta-analysis of randomised trials of antiplatel... | 2002 | BMJ | 6.9K | ✓ |
| 5 | Prasugrel versus Clopidogrel in Patients with Acute Coronary S... | 2007 | New England Journal of... | 6.7K | ✓ |
| 6 | Refining Clinical Risk Stratification for Predicting Stroke an... | 2009 | CHEST Journal | 6.6K | ✓ |
| 7 | A randomised, blinded, trial of clopidogrel versus aspirin in ... | 1996 | The Lancet | 6.5K | ✕ |
| 8 | Antithrombotic Therapy for VTE Disease | 2012 | CHEST Journal | 6.1K | ✓ |
| 9 | Prevention of Venous Thromboembolism | 2004 | CHEST Journal | 5.9K | ✕ |
| 10 | 2018 Guidelines for the Early Management of Patients With Acut... | 2018 | Stroke | 5.4K | ✕ |
In the News
Exclusion of Venous Thrombo-Embolism With a New ...
ClinicalTrials.gov Hide glossary#### Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms
Predicting venous thromboembolism among hospitalized adults: a protocol for development and validation of an implementable real-time prognostic model
# Predicting venous thromboembolism among hospitalized adults: a protocol for development and validation of an implementable real-time prognostic model * Protocol * Open access * Published:08 Sept...
2025 ESVM Guidelines on interventional treatment of venous thromboembolism - PubMed
****The number of endovascular interventional procedures for catheter-based therapy (CBT) of acute venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), h...
Venous Thromboembolism: Diagnosis and Treatment | AAFP
Copyright ©2025 by the American Academy of Family Physicians.
Practice Change for Cancer Patients at Risk for Venous ...
_API-CAT was funded by Bristol-Myers Squibb (BMS)-Pfizer Alliance._ _Dr. Mahé reported consultancy fees from AstraZeneca and research grants and speaker fees from BMS-Pfizer and Leo Pharma._
Code & Tools
The Wells Criteria for Deep Vein Thrombosis (DVT) is a clinical prediction rule used to assess the probability of deep vein thrombosis (DVT) in pat...
I created this based on my original code using python/flask. This calculator can be used to calculate the Wells Score, used in clinical prediction ...
No clinical, policy or safety conclusions must be drawn from the contents of this repository. # About the OpenSAFELY framework The OpenSAFELY fra...
No clinical, policy or safety conclusions must be drawn from the contents of this repository. # About the OpenSAFELY framework The OpenSAFELY fra...
This repository contains the code and the report for the master thesis: *Predicting venous thromboembolic events in patients with cancer using a ne...
Recent Preprints
Venous Thromboembolism
- Complication Rates of Central Venous Catheters: A Systematic Review and Meta-Analysis JAMA Internal Medicine Research March 4, 2024 This systematic review and meta-analysis summarizes curre...
Venous Thromboembolism: Diagnosis and Treatment | AAFP
Venous thromboembolism (VTE) presents as deep venous thrombosis (DVT) or pulmonary embolism (PE). VTE is the third most common fatal cardiovascular condition in the United States. Clinical predicti...
Venous Thromboembolism: Diagnosis and Treatment
Venous thromboembolism (VTE) presents as deep venous thrombosis (DVT) or pulmonary embolism (PE). VTE is the third most common fatal cardiovascular condition in the United States. Clinical predicti...
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy Chapter: 11.4. Management of acute venous thromboembolism
# 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy Chapter: 11.4. Management of acute venous thromboembolism ## By the ESC WG on Pulmonary Circulation & RVF 01 Oct 202...
Venous thromboembolism — treating with the appropriate anticoagulant and duration
This ACE Clinical Guideline (ACG) provides evidence-based recommendations on selecting an appropriate anticoagulant and treatment duration for different patient groups with venous thromboembolism (...
Latest Developments
Recent developments in venous thromboembolism (VTE) research as of February 2026 include advances in diagnosis, management, and interventional treatments, with ongoing updates from major symposiums such as the Johns Hopkins VTE Symposium scheduled for March 2026 (MDPI; Johns Hopkins; pubmed). Key areas of progress involve new anticoagulant drugs, minimally invasive thrombectomy devices, improved imaging technologies, and validated risk assessment models, with recent guidelines emphasizing efficient diagnostic strategies (MDPI; ASH; JAMA).
Sources
Frequently Asked Questions
What are the main components of antithrombotic therapy for VTE?
Antithrombotic therapy for VTE disease involves anticoagulants selected based on patient risk and bleeding profile. Kearon et al. (2012) in "Antithrombotic Therapy for VTE Disease" recommend initial parenteral therapy followed by oral agents for acute and extended treatment. Therapy duration varies from 3 months to indefinite based on recurrence risk.
How is VTE risk stratified in clinical practice?
VTE risk stratification uses clinical prediction rules like Wells' Criteria for DVT and PE to determine pretest probability. These tools guide diagnostic imaging decisions. Low-probability patients may avoid immediate testing, reducing unnecessary procedures.
What prophylaxis strategies prevent VTE?
Prophylaxis strategies include pharmacologic agents like low-molecular-weight heparin and mechanical methods. Geerts et al. (2004) in "Prevention of Venous Thromboembolism" provide recommendations for surgical patients, showing reduced VTE events with tailored regimens. Cancer patients require extended prophylaxis per guidelines.
What role do direct oral anticoagulants play in VTE management?
Direct oral anticoagulants like rivaroxaban offer noninferior efficacy to warfarin for VTE-related stroke prevention. Patel et al. (2011) in "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation" report lower intracranial bleeding rates with rivaroxaban. These agents simplify outpatient management.
How are VTE guidelines applied in special populations like cancer patients?
Cancer-associated thrombosis management favors low-molecular-weight heparin over vitamin K antagonists initially. Guidelines emphasize prolonged prophylaxis due to elevated recurrence risks. Recent ACE Clinical Guidelines specify anticoagulant selection for cancer patients with VTE.
Open Research Questions
- ? How can real-time prognostic models improve VTE prediction accuracy in hospitalized adults?
- ? What are the optimal durations and agents for anticoagulation in cancer-associated VTE?
- ? Which endovascular interventions yield the best outcomes for acute VTE compared to systemic therapies?
- ? How do central venous catheter complication rates influence prophylaxis protocols?
- ? What refinements to Wells' Criteria enhance diagnostic precision for diverse populations?
Recent Trends
Endovascular interventions for acute VTE have increased, as noted in 2025 ESVM Guidelines.
New protocols develop real-time prognostic models for hospitalized adults predicting VTE. Guidelines like 2025 ESC for pregnancy-related VTE and ACE on anticoagulant duration address special populations.
Meta-analyses quantify central venous catheter complication rates.
Research Venous Thromboembolism Diagnosis and Management with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Venous Thromboembolism Diagnosis and Management with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers